
Minerva Surgical, Inc. (UTRS)
UTRS Stock Price Chart
Explore Minerva Surgical, Inc. interactive price chart. Choose custom timeframes to analyze UTRS price movements and trends.
UTRS Company Profile
Discover essential business fundamentals and corporate details for Minerva Surgical, Inc. (UTRS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
22 Oct 2021
Employees
174.00
Website
https://minervasurgical.comCEO
Darin Hammers
Description
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
UTRS Financial Timeline
Browse a chronological timeline of Minerva Surgical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 Feb 2025
Earnings released on 27 Dec 2024
Earnings released on 9 Aug 2024
Earnings released on 14 Jun 2024
Earnings released on 19 Mar 2024
Earnings released on 13 Nov 2023
EPS came in at -$0.81 surpassing the estimated -$1.00 by +19.00%, while revenue for the quarter reached $11.97M , missing expectations by -13.92%.
Stock split effective on 2 Oct 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 2 Aug 2023
EPS came in at -$1.00 surpassing the estimated -$1.80 by +44.44%, while revenue for the quarter reached $13.39M , beating expectations by +1.37%.
Earnings released on 2 May 2023
EPS came in at -$2.40 falling short of the estimated -$2.20 by -9.09%, while revenue for the quarter reached $12.53M , meeting expectations.
Earnings released on 21 Mar 2023
EPS came in at -$4.00 falling short of the estimated $0.21 by -2.00K%, while revenue for the quarter reached $13.80M , missing expectations by -7.97%.
Earnings released on 14 Nov 2022
EPS came in at -$8.00 falling short of the estimated -$5.60 by -42.86%, while revenue for the quarter reached $12.59M , missing expectations by -16.08%.
Earnings released on 9 Aug 2022
EPS came in at -$4.00 surpassing the estimated -$6.80 by +41.18%, while revenue for the quarter reached $12.97M .
Earnings released on 11 May 2022
EPS came in at -$7.60 falling short of the estimated -$6.20 by -22.58%, while revenue for the quarter reached $10.94M , beating expectations by +1.53%.
Earnings released on 8 Mar 2022
EPS came in at -$0.26 surpassing the estimated -$0.29 by +10.34%, while revenue for the quarter reached $13.65M , beating expectations by +25.76%.
Earnings released on 2 Dec 2021
EPS came in at $4.87 surpassing the estimated -$0.44 by +1.21K%, while revenue for the quarter reached $12.51M .
Earnings released on 25 Oct 2021
EPS came in at -$13.82 , while revenue for the quarter reached $14.11M .
Earnings released on 31 Mar 2021
EPS came in at -$14.66 , while revenue for the quarter reached $11.84M .
Earnings released on 31 Dec 2020
EPS came in at -$0.31 , while revenue for the quarter reached $13.55M .
Earnings released on 30 Sept 2020
EPS came in at -$7.18 , while revenue for the quarter reached $12.28M .
UTRS Stock Performance
Access detailed UTRS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.